{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:08:27Z","timestamp":1793207307709,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1136\/ard.2010.133850","type":"journal-article","created":{"date-parts":[[2010,11,21]],"date-time":"2010-11-21T01:14:34Z","timestamp":1290302074000},"page":"447-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus"],"prefix":"10.1016","volume":"70","author":[{"given":"Christian","family":"Dejaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Duftner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A","family":"Cimmino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Maradit-Kremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.133850_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00108-008-2274-x","article-title":"[Polymyalgia rheumatica]","volume":"50","author":"Duftner","year":"2009","journal-title":"Internist (Berl)"},{"key":"10.1136\/ard.2010.133850_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"key":"10.1136\/ard.2010.133850_bib4","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica","volume":"40","author":"Gabriel","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6 Suppl 47","key":"10.1136\/ard.2010.133850_bib6","first-page":"130","article-title":"Management guidelines and outcome measures in polymyalgia rheumatica (PMR)","volume":"25","author":"Dasgupta","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archinte.159.6.577","article-title":"Corticosteroid requirements in polymyalgia rheumatica","volume":"159","author":"Weyand","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2010.133850_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-146-9-200705010-00005","article-title":"Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial","volume":"146","author":"Salvarani","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2010.133850_bib9","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/art.23095","article-title":"Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study","volume":"57","author":"Catanoso","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","article-title":"Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial","volume":"141","author":"Caporali","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2010.133850_bib11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.22771","article-title":"The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission","volume":"57","author":"Leeb","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.23338","article-title":"Performance of the polymyalgia rheumatica activity score for diagnosing disease flares","volume":"59","author":"Binard","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/ard.2002.002618","article-title":"EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT)","volume":"62","author":"Leeb","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.133850_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/ard.2003.011379","article-title":"A disease activity score for polymyalgia rheumatica","volume":"63","author":"Leeb","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.133850_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/ard.2008.088526","article-title":"Validity of the polymyalgia rheumatica activity score in primary care practice","volume":"68","author":"Binard","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.133850_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.22630","article-title":"Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios","volume":"57","author":"Binard","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib17","first-page":"270","article-title":"Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey","volume":"35","author":"Dasgupta","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2010.133850_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.rdc.2008.05.007","article-title":"Epidemiology of osteoarthritis","volume":"34","author":"Zhang","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.2010.133850_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/ard.2006.062422","article-title":"The public neglect of rheumatic diseases: insights from analyses of attendees in a musculoskeletal disease awareness activity","volume":"66","author":"Machold","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.133850_bib21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.133850_bib22","first-page":"157","article-title":"Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease","volume":"9","author":"Hachulla","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib23","first-page":"1945","article-title":"Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis","volume":"26","author":"Narv\u00e1ez","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/art.21585","article-title":"Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms","volume":"53","author":"Pego-Reigosa","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W","article-title":"Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study","volume":"41","author":"Salvarani","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.20901","article-title":"Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective followup study","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sarh.2000.8366","article-title":"Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study","volume":"30","author":"Cantini","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0954-6820.1981.tb11604.x","article-title":"Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids","volume":"209","author":"Bengtsson","year":"1981","journal-title":"Acta Med Scand"},{"key":"10.1136\/ard.2010.133850_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.0954-6820.1979.tb06077.x","article-title":"A ten-year survey of 53 patients","volume":"205","author":"von Knorring J. Treatment and prognosis in polymyalgia rheumatica and temporal arteritis","year":"1979","journal-title":"Acta Med Scand"},{"key":"10.1136\/ard.2010.133850_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.42.4.374","article-title":"Polymyalgia rheumatica and corticosteroids: how much for how long?","volume":"42","author":"Behn","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.133850_bib31","first-page":"65","article-title":"Relapse in a population based cohort of patients with polymyalgia rheumatica","volume":"32","author":"Kremers","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib32","first-page":"1326","article-title":"The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study","volume":"26","author":"Gonz\u00e1lez-Gay","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib33","first-page":"99","article-title":"Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis","volume":"25","author":"Bahlas","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/art.21160","article-title":"Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease","volume":"53","author":"Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/art.22548","article-title":"Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica","volume":"57","author":"Maradit Kremers","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib36","first-page":"1333","article-title":"Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis","volume":"26","author":"Proven","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/030097401753180327","article-title":"Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients","volume":"30","author":"Myklebust","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0002-9343(85)90309-2","article-title":"Polymyalgia rheumatica. Duration of therapy and long-term outcome","volume":"79","author":"Ayoub","year":"1985","journal-title":"Am J Med"},{"key":"10.1136\/ard.2010.133850_bib39","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta2030","article-title":"Consensus development methods, and their use in clinical guideline development","volume":"2","author":"Murphy","year":"1998","journal-title":"Health Technol Assess"},{"key":"10.1136\/ard.2010.133850_bib40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"10.1136\/ard.2010.133850_bib41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2010.133850_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/37.2.189","article-title":"An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica","volume":"37","author":"Dasgupta","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.47.9.733","article-title":"Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients)","volume":"47","author":"Delecoeuillerie","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.133850_bib44","first-page":"1550","article-title":"The use of methotrexate in polymyalgia rheumatica","volume":"23","author":"Feinberg","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib45","first-page":"624","article-title":"Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study","volume":"23","author":"Ferraccioli","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.22777","article-title":"Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica","volume":"57","author":"Hutchings","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib47","first-page":"1660","article-title":"A longterm prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica","volume":"22","author":"Krogsgaard","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib48","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/rheumatology\/keg293","article-title":"Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy","volume":"42","author":"Martinez-Taboada","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.133850_bib49","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/BF02207931","article-title":"Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients","volume":"14","author":"Mertens","year":"1995","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.55.4.218","article-title":"Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?","volume":"55","author":"van der Veen","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.133850_bib51","first-page":"502","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica","volume":"29","author":"Amoli","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.rhu.0000231381.21179.e6","article-title":"Peripheral musculoskeletal manifestations in polymyalgia rheumatica","volume":"12","author":"Ceccato","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1196\/annals.1351.030","article-title":"Is the course of steroid-treated polymyalgia rheumatica more severe in women?","volume":"1069","author":"Cimmino","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1136\/ard.2010.133850_bib54","first-page":"395","article-title":"Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids","volume":"26","author":"Cimmino","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib55","first-page":"748","article-title":"Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6","volume":"29","author":"Cutolo","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archinte.1997.00440240081012","article-title":"Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome","volume":"157","author":"Gonz\u00e1lez-Gay","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2010.133850_bib57","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/ard.52.12.847","article-title":"The clinical and laboratory course of polymyalgia rheumatica\/giant cell arteritis after the first two months of treatment","volume":"52","author":"Kyle","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.133850_bib58","first-page":"1340","article-title":"Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis","volume":"17","author":"Lundberg","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.133850_bib59","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.23924","article-title":"Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse\/recurrence risk","volume":"59","author":"Pulsatelli","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.133850_bib60","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/ard.54.8.640","article-title":"Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis","volume":"54","author":"Salvarani","year":"1995","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724146444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724146444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.133850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:58:16Z","timestamp":1737244696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724146444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0003496724146444"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.133850","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.133850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}